193 related articles for article (PubMed ID: 37954483)
1. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.
Fan Z; Shou L
Ther Adv Hematol; 2023; 14():20406207231208973. PubMed ID: 37954483
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of the Controlling Nutritional Status (CONUT) score in patients with lymphoma: a meta-analysis.
Li L; Shou L
BMJ Open; 2024 Mar; 14(3):e078320. PubMed ID: 38453197
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients.
Wu XB; Hou SL; Liu H
World J Clin Cases; 2021 Nov; 9(32):9825-9834. PubMed ID: 34877321
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
Wang J; Zhou X; Liu Y; Li Z; Li X
PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis.
Dong M; Shi Y; Yang J; Zhou Q; Lian Y; Wang D; Ma T; Zhang Y; Mi Y; Gu X; Fan R
Ther Adv Med Oncol; 2020; 12():1758835920937425. PubMed ID: 32699557
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
Zhang Y; Sun Y; Zhang Q
Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological role of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: A meta-analysis.
Cao D; Zhang Z
Front Oncol; 2023; 13():1169749. PubMed ID: 37064090
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological role of pretreatment systemic immune-inflammation index in patients with oral squamous cell carcinoma: a meta-analysis.
Zhang J; Dai S
Front Oncol; 2023; 13():1303132. PubMed ID: 38293698
[TBL] [Abstract][Full Text] [Related]
9. Revealing the prognostic and clinicopathological significance of systemic immune-inflammation index in patients with different stage prostate cancer: A systematic review and meta-analysis.
Qi W; Zhou Y; Liu Z; Wang J; Lv G; Zhong M; Wang W; Li R; Chen S; Shi B; Zhu Y
Front Med (Lausanne); 2022; 9():1052943. PubMed ID: 36388917
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis.
Zhou Y; Dai M; Zhang Z
Front Oncol; 2022; 12():814727. PubMed ID: 35186750
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.
Jin M; Yuan S; Yuan Y; Yi L
Front Oncol; 2021; 11():735803. PubMed ID: 34950577
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
Meng L; Yang Y; Hu X; Zhang R; Li X
J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.
Mao H; Yang F
Front Oncol; 2023; 13():1193962. PubMed ID: 37342198
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis.
Zeng Z; Xu S; Wang D; Qin G
Syst Rev; 2022 Nov; 11(1):247. PubMed ID: 36403072
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of the Systemic Immune-Inflammation Index in Patients With Cholangiocarcinoma: A Meta-Analysis.
Liu XC; Jiang YP; Sun XG; Zhao JJ; Zhang LY; Jing X
Front Oncol; 2022; 12():938549. PubMed ID: 35875153
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Systemic Immune Inflammatory Index and Prognosis of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review.
Huang W; Luo J; Wen J; Jiang M
Front Surg; 2022; 9():898304. PubMed ID: 35846963
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis.
Chen Y; Zhang Z; Fang Q; Jian H
Cancer Cell Int; 2019; 19():245. PubMed ID: 31572062
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis.
Qiu Y; Zhang Z; Chen Y
Front Oncol; 2021; 11():537140. PubMed ID: 33777726
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of the pretreatment systemic immune-inflammation index in patients with glioma: A meta-analysis.
Zhang S; Ni Q
Front Neurol; 2023; 14():1094364. PubMed ID: 36970508
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological significance of Systemic Immune-Inflammation Index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis.
Wang Y; Ni Q
Ann Med; 2023 Dec; 55(1):808-819. PubMed ID: 36892953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
